Biotech Events And Company Events
Angiopoietin-1 Was Found to Has Control over Fish Brain Size and Intelligence
Recently, a new study conducted by scientists at UCL, Stockholm University and University of Helsinki found that a single gene called Angiopoietin-1 (Ang-1) controls brain size and intelligence in fish. Scientists in this study employed guppies and zebra fish as models. To their
Creative BioMart Improved Its Biomarker Service
New York, May 25, 2015-Creative BioMart is pleased to announce that now it can provide improved biomarker service for drug development. Creative BioMart has been providing biomarker services for several years. The company is growing rapidly these years. And with the introduction of more advanced
Creative BioMart Launched Protein Extract Services
April 21, 2015-Creative BioMart, a US influential company that aims to provide first rate biotech products and services worldwide, has launched protein extraction services this very day. In the official speaker’s words, this update is to simplify protein isolation and purification. Cell
New Findings about Plexin D1 You May Want to Know
Generally speaking, men tend to store fat in the belly while women are prone to store more fat on the hips and thighs. These actually produce the classic “apple” and “pear” shapes. According to previous studies, people who carry more weight around the bellies are more likely
Creative BioMart Launches Promotions for Proteins, Enzymes and Custom Services this New Year
On December 22, 2014, just a few days before Christmas, Creative BioMart announced that it has launched the promotion of its featured Products. This special offer will expire on 1/31/2015. This promotion is for featured proteins, enzymes and custom services. Customers can save 10% for
Garlic And Broccoli Were Found to Help Improve Cancer Treatment
Our immune system is developed to remove things that are alien to our bodies. However. Sometimes, some types of cancer cells contain mechanisms that block the immune system’s ability to recognize them. And some stimulating molecules can over-activate the immune system and cause it to
Antibodies Were Turned into Highly Tuned Nanobodies by New Technology
Antibodies, one of the most useful tools in biology and medicine, play an important role in recognizing and homing in on molecular targets. Nanobodies, the tiny cousins of antibodies, can do the same work. And because of their simplicity, Nanobodies are comparatively easier to produce. Unluckily,
The Sixth PEGS Europe Will Come Next Week
PEGS (Protein & Antibody Engineering Summit) Europe, the largest European event covering all aspects of protein and antibody engineering, will be held next week from November 3rd to 7th in Lisbon, Portugal. According to the official office, this year’s summit mainly focuses on topics
Creative BioMart Launched a Novel Service for Transcription Factor Assay
When: October 13, 2014 Where: 45-16 Ramsey Road Shirley What: Launch of new service Introduction: Creative BioMart announced today for the official release of its new service--transcription factor assay service which is backed by various of tools that can meet various of needs and
Creative BioMart Conducted a Lecture about Enzymes Market
When: 2:00pm to 4:00pm, September 23, 2014 Where: Creative BioMart's meeting room, 45-16 Ramsey Road Shirley What: An academic lecture about enzymes market Introduction: Creative BioMart conducted an academic lecture to talk about enzymes market worldwide in the aim of having a
Biosimilars Global Congress 2014 Europe within One Week
Biosimilars Global Congress 2014 Europe is going to be held in Sep 17th to Sep 19th 2014 from 8:30 am to 6:00 pm in Financial District, Boston. This Congress is to give a platform for interactive discussion and communication about practical strategies on challenges, innovations, technologies and
The 4th International Conference on Biotechnology and Environment Management 2014
When September 15 to 16, 2014 Where Paris, France Introduction The 4th International conference on Biotechnology and Environment Management 2014 (ICBEM 2014) is a forum where innovative academics and industrial experts in the field of biotechnology and environment can get together to promote
Creative BioMart Seminar---For Downstream Processing Development
August 12, 2014---Creative BioMart launched a seminar to discuss the development of downstream processing. Participants include Creative BioMart staff scientists and sale staff. Holding this seminar, Creative BioMart wants to expand the service for downstream processing. Downstream processing is
Creative BioMart Launches Promotion Activity for Featured Recombinant Proteins This August
Creative BioMart Launches Promotion Activity for Featured Recombinant Proteins This August
Statistics: Research Focus Is Put on Recombinant Proteins
According to the results of one of our online surveys, most listed companies have placed their emphasis on the development of recombinant proteins. Meanwhile according to the statistics of financial weekly newspaper, nine pharmaceutical companies have mentioned that they have made
Big Shuffle in Pharmaceutical Industry: New Round of GMP Certification Creates Chance for Company Acquisition
According to China Food and Drug Administration (CFDA) report, as of December 31, 2013, more than seven hundreds of enterprises in sterile pharmaceutical manufacture in China have approved the newly revised GMP certification, however, more than four hundreds of others failed and fallen into
Drug Company Concern: Trend in Pharmaceutical Information
On January 3rd, the Public Accounts Committee, British House of Commons published a report with regard to the reservation issue of Tamiflu (a kind of influenza drug that is usually used in the treatment of both seasonal flu and swine flu), which sparked a discussion about whether the clinical
2013 Year in Review: Creative BioMart’s Scientific Expertise in Recombinant Protein Production
It’s the time for the 2013 year in review for Creative BioMart considering the physical time is coming. We’d love to share the experience with you. The production of recombinant proteins can be a tricky process that consumes time, manpower and money. Therefore specialized
Worldwide Biotech/Biopharma Alliance (Dec. 20 – Dec. 19)
On Dec. 20, 2013, PeptiDream Inc announced that they have entered into a Collaboration and License Agreement with US-based Eli Lilly and Company (Lilly) (LLY). Under the agreement, PeptiDream will identify macrocyclic peptides as potential drug candidates for disease targets being pursued by Lilly.
EU Regulatory: Giant Pharmaceuticals Are Fined Again for Disorganizing Market
On last Tuesday, EU regulators announced another pecuniary penalty event on pharmaceutical giant Johnson & Johnson and Novartis because they tried to stop the selling launch of a cheaper painkiller biosimilar. They have to accept a fine of €16.3 million (i.e. $ 22 million); meanwhile
Creative BioMart “Morning Talk”: Give Answers to Diagnostic Enzymes
Generally speaking, enzymes used for clinical purpose or intended metabolic investigation are diagnostic enzymes. Examples of diagnostic enzymes include Adenosine Aminohydrolase (ADA), Neuron Specific Enolase (NSE), Catalase (CAT), Glucose Oxidase (GOD), Glycerol Kinase (GK/GYK), Malate
Broader Portfolio of Recombinant Antibodies Launched by Creative BioMart
Creative BioMart, a world leader in immunoassay development and contract manufacturing, expanded its unique range of Recombinant Antibodies at the Clinical Lab Expo. Antibodies are vital research tools for cell biology and biomedical research. But it is generally difficult to access
Creative BioMart Updates New Product—Thrombin
Creative BioMart will update its products on a daily basis. This time, the thrombin is “on the shelf” and intended customers are accessible to purchase and inquire related information by contacting out experts. Or some of necessary information can be found on our official website.
Retrospective Viewpoint: Biotechnology Companies Keep Going with Mergers
In face of patent expiration or other threats, big pharmaceutics are facing challenges too. In priority, innovative technology or novel developments are necessary. On 2010, Celgene declared the acquisition of ABII for $2.9 billion for cancer treatment. On May 2011, Shire declared the
Worldwide BiotechBiopharma Alliance within the Two Days
On Nov. 14, 2013, MRC Technology announced that it is collaborating with Dr Zameel Cader at Oxford University’s Nuffield Department of Clinical Neurosciences, to screen selective and potent potassium channel activators to develop novel therapeutic interventions in migraine. On Nov. 13,